Metaclipse Therapeutics Corp

Atlanta, GA

UEI
MU6JZBDZR8X1
CAGE
6BYQ1
Primary NAICS
541713 Research and Development in Nanotechnology
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
3342 International Park Dr SE, Atlanta, GA 30316, USA
Website
metaclipse.com
Employees
1-10
Estimated annual revenue
$1M-$10M
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Quick answers

What is Metaclipse Therapeutics Corp's UEI?

Metaclipse Therapeutics Corp's Unique Entity ID (UEI) in SAM.gov is MU6JZBDZR8X1.

What is Metaclipse Therapeutics Corp's CAGE code?

Metaclipse Therapeutics Corp's CAGE code is 6BYQ1.

What is Metaclipse Therapeutics Corp's primary NAICS code?

Metaclipse Therapeutics Corp's primary NAICS code is 541713 (Research and Development in Nanotechnology).

Where is Metaclipse Therapeutics Corp located?

Metaclipse Therapeutics Corp's physical address in SAM.gov is 3342 International Park Dr SE, Atlanta, GA 30316, USA.

Is Metaclipse Therapeutics Corp registered in SAM.gov?

Yes. Metaclipse Therapeutics Corp's SAM.gov registration is active through June 9, 2027.

What is Metaclipse Therapeutics Corp's most recent federal award?

Metaclipse Therapeutics Corp's most recent federal contract award is Sbir concept award for development of therapeutic or preventative technologies for treatment or prevention of… (75N91025C00038), from National Cancer Institute, on September 5, 2025.

On GovTribe

See Metaclipse Therapeutics Corp's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors